On Dec. 3, 2021, Gavi, the Vaccine Alliance, approved a new malaria vaccination programme to support the introduction, procurement and delivery of the malaria vaccine to Gavi-eligible countries in sub-Saharan Africa.

An initial investment of US$ 155.7 million for 2022-2025 initiated the implementation of this additional tool in the fight against malaria alongside currently recommended malaria control interventions.